- Home
- RETO vs PTIX Comparison
RETO vs PTIX Comparison
Compare RETO & PTIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RETO
- PTIX
- Stock Information
- Founded
- RETO 1999
- PTIX 1994
- Country
- RETO China
- PTIX United States
- Employees
- RETO N/A
- PTIX N/A
- Industry
- RETO Multi-Sector Companies
- PTIX Biotechnology: Pharmaceutical Preparations
- Sector
- RETO Consumer Discretionary
- PTIX Health Care
- Exchange
- RETO Nasdaq
- PTIX Nasdaq
- Market Cap
- RETO 7.3M
- PTIX 6.3M
- IPO Year
- RETO 2017
- PTIX 2016
- Fundamental
- Price
- RETO $2.57
- PTIX $2.31
- Analyst Decision
- RETO
- PTIX
- Analyst Count
- RETO 0
- PTIX 0
- Target Price
- RETO N/A
- PTIX N/A
- AVG Volume (30 Days)
- RETO 18.2K
- PTIX 78.1K
- Earning Date
- RETO 05-05-2026
- PTIX 12-05-2025
- Dividend Yield
- RETO N/A
- PTIX N/A
- EPS Growth
- RETO N/A
- PTIX N/A
- EPS
- RETO N/A
- PTIX N/A
- Revenue
- RETO $2,109,956.00
- PTIX N/A
- Revenue This Year
- RETO N/A
- PTIX N/A
- Revenue Next Year
- RETO N/A
- PTIX N/A
- P/E Ratio
- RETO N/A
- PTIX N/A
- Revenue Growth
- RETO 16864.81
- PTIX N/A
- 52 Week Low
- RETO $2.50
- PTIX $1.83
- 52 Week High
- RETO $61.50
- PTIX $14.28
- Technical
- Relative Strength Index (RSI)
- RETO 56.51
- PTIX 46.39
- Support Level
- RETO $2.66
- PTIX $1.95
- Resistance Level
- RETO $2.86
- PTIX $2.25
- Average True Range (ATR)
- RETO 0.19
- PTIX 0.19
- MACD
- RETO -0.05
- PTIX 0.05
- Stochastic Oscillator
- RETO 11.48
- PTIX 88.18
About RETO ReTo Eco-Solutions Inc.
ReTo Eco-Solutions Inc is a manufacturer and distributor of eco-friendly construction materials and fly ash, as well as equipment used to produce these eco-friendly construction materials. The company engaged in providing consultation, design, project implementation, and construction of urban ecological environments for capturing, controlling, and reusing rainwater. It operates through two segments, namely Machinery and Equipment sales, and Technology Consulting and other services. The company earns its revenue from the Machinery and Equipment sales segment. Geographically, it derives a majority of its revenue from China.
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.